Acute Myelogenous Leukemia (AML) & Chronic Myelogenous Leukemia (CML)for USMLE

Поделиться
HTML-код
  • Опубликовано: 18 окт 2024
  • Handwritten video lecture on Acute Myelogenous Leukemia (AML) and Chronic Myelogenous Leukemia (CML) for the USMLE. Will discuss Pathophysiology, Signs and Symptoms, Treatment and Prognosis
    Pathophysiology of Myelogenous Leukemia
    The stem cells are found in the bone marrow which gives rise to myeloid stem cells which then give rise to myelobast and then the granulocytes (Eosinophils, Basophils, Neutrophils)
    In Acute Myelogenous Luekemia there is an increase in Myeloblasts and may even involve myeloid stem cell which will affect red blood cells and platelets. In Chronic Myelogenous Leukemia there is an increase in Tyrosine Kinase which increases the number of the granulocytes that are found.
    ACUTE MYELOGENOUS LUEKEMIA
    Arrests at precursor stage with more than 20percent blasts in Bone Marrow. Blasts accumulate in bone marrow and goes to peripheral tissue. Common to have decreased Red Blood Cells and Platelets as Bone marrow gets crowded. Changes in Growth Factor causes arrest of development or decreased apoptosis.
    Myelodysplastic syndrome is a minor change in stem cells that is not cancerous yet, but it commonly develops into cancer.
    CLASSIFICATION - Currently classification is adopted by WHO which is based on therapeutic targets.
    1. AML wiith recurrent abnormalities
    a. 8 21 translocation,
    b. t(15 17) Promyelocytic Leukemia
    i. Auer rods (M3).
    ii. PML RaR translocation (may be treated with retinoic acid)
    2. AML with Myelodysplastic Syndrome (Poor Prognosis)
    3. AML that is therapy related - due to cytotoxic agents
    4. AML, not specified - classified from M0 to M7
    CLINICAL - Sudden onset also may have thrombocytopenia, anemia, bone main and may affect liver, spleen, lymph node. After treatment patient may experience tumor lysis syndrome (high K, High Uric acid, High Phosphate, Low Calcium)
    INVESTIGATIONS - Usually show normocytic anemia and thrombocytopenia. Blood smear shows blasts which are myeloperoxidase positive. Bone marrow aspiration will show hypercellular with more than 20 percent blasts. Cytogenetic analysis help with prognosis.
    TREATMENT - Induction consists of 7 days of IV cytarabine with 3 days of short acting anthracycline to kills as much of blasts as possible. Consolidation to mop up left over with high dose cytarabine. If remission favorable and young age then continue more cycles of cytarabine. If no resmission or comorbidities than perform stem cell transplant and investigation therapies.
    PROGNOSIS - depends on age. As age increases the prognosis is worse
    CHRONIC MYELOGENOUS LUEKEMIA
    PATHOGENESIS - Translocation between chromosome 9 (ABL1) and Chromosome 22 (BCL). ABL is responsible for production of tyrosine kinase which is tightly regulated. ABL transfers over to BCL on chromosome 22 known as ABL BCR fusion and the Philadelphia chromosome. This leads to constant production of tyrosine kinase.
    CLINICAL - has more insidious onset and found as incidental finding. Chronic phase is symptomatic but can be controlled with treatment. Accelerated phase there is an increase in the number of blasts and will be less responsive to treatment. Final stage is blast crisis is when it transforms to AML with extramedullary syndromes.
    INVESTIGATIONS - High level of leukocytosis that are LAP negative to rule out leukemoid reaction. Cytogenetic analysis is diagnostic. Flow cytometry identifies CD Markers present.
    TREATMENT - In chronic phase give imatinib meyslete which is a tyrosine kinase inhibitor, but this is not a cure and the disease is always there. Accelerated blast crisis then look for hematopoietic stem cell transplant which is curative. Interferon alpha and Busulfan can be used while waiting for donor.

Комментарии • 15

  • @waadaamir7153
    @waadaamir7153 6 лет назад +1

    Thank you very much, for breaking down such complex topic into small digestive pieces easy to comperhend easy to memorize😉

  • @tshephobodiba2283
    @tshephobodiba2283 7 лет назад

    Thank you for simplifying such a complex topic. I'm currently rotating in paediatric oncology and have been reading this topics countless times with little understanding... I feel great about this now.

  • @rustyfo1
    @rustyfo1 8 лет назад +1

    Great video. Really came in handy since I have an upcoming hematology exam, so thank you!

  • @umarjin9160
    @umarjin9160 8 лет назад +1

    lovely lecture... i wish i cud have been taught in this manner at the start of my career.. very well done Boss...

  • @ohunemouche
    @ohunemouche 8 лет назад +2

    This is such a great video! You should do one about CLL and ALL!
    This has saved me so much study time! Keep up with the hard work !!!

    • @thestudyspot
      @thestudyspot  8 лет назад

      +Ming Wst I am glad I can help. BTW, I do have a video on CLL/ALL. Enjoy!
      ruclips.net/video/HMoV-NhWNDY/видео.html

    • @ohunemouche
      @ohunemouche 8 лет назад

      +the study spot It's a private video, I can't open the link.. :/

    • @thestudyspot
      @thestudyspot  8 лет назад

      +Sarah Woon Yeah it was private for some strange reason. I made it public now so you can go ahead and watch it

    • @ohunemouche
      @ohunemouche 8 лет назад

      THANK YOU SO MUCH YOURE A LEGEND!!

  • @amandangolobe9749
    @amandangolobe9749 7 лет назад

    thank you for the lecture. Easy to understand.

  • @doc.bhaskarreddybijjam2312
    @doc.bhaskarreddybijjam2312 8 лет назад

    Very nice video..

  • @livingwithamlcom
    @livingwithamlcom 7 лет назад

    good video

  • @drsmritipandey
    @drsmritipandey 6 лет назад

    Tq sir

  • @mollalgnworkneh3806
    @mollalgnworkneh3806 7 лет назад

    10Q!!!!